Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 275 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Revelation Biosciences Inc | REVB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0773 | -3.67% | 2.03 | 04:13:19 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.1073 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 4 | 275 | - | 1.7801 - 39.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 04:13:19 | formt | 240 | US$ 2.03 | USD |
Revelation Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.1k | 209.91k | - | 0 | -120k | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Revelation Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REVB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.14 | 2.31 | 2.03 | 2.13 | 23,405 | -0.11 | -5.14% |
| 1 Month | 2.55 | 2.84 | 1.7801 | 2.22 | 43,361 | -0.52 | -20.39% |
| 3 Months | 2.62 | 4.34 | 1.7801 | 3.02 | 211,237 | -0.59 | -22.52% |
| 6 Months | 19.797 | 25.26 | 1.7801 | 7.84 | 275,262 | -17.77 | -89.75% |
| 1 Year | 30.90 | 39.00 | 1.7801 | 15.59 | 211,656 | -28.87 | -93.43% |
| 3 Years | 8,799.00 | 10,237.50 | 1.7801 | 982.94 | 1,274,015 | -8,796.97 | -99.98% |
| 5 Years | 8,799.00 | 10,237.50 | 1.7801 | 982.94 | 1,274,015 | -8,796.97 | -99.98% |
Revelation Biosciences Description
| Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. |
